Clinical Trial Update: Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of methylprednisolone after flow-diverter stent implantation in patients with unruptured intrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke
• Unruptured Intracranial Aneurysm

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Duan Chuanzhi | Conditions: Unruptured Intracranial Aneurysms, Cerebrovascular Event | Phase 4 | Status: NOT_YET_RECRUITING